Harmony Biosciences Holdings (HRMY)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Net income (ttm)	US$ in thousands	145,493	122,625	114,993	137,702	128,853	150,755	200,237	189,468	181,468	155,673	58,110	48,696	34,597	11,675	23,204
Revenue (ttm)	US$ in thousands	710,199	672,548	630,000	585,184	548,499	507,747	476,532	451,378	419,060	383,158	319,980	290,957	268,890	236,824	233,336
Net profit margin		20.49%	18.23%	18.25%	23.53%	23.49%	29.69%	42.02%	41.98%	43.30%	40.63%	18.16%	16.74%	12.87%	4.93%	9.94%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $145,493K ÷ $710,199K
= 20.49%

Net profit margin is a key profitability ratio that indicates the percentage of revenue that remains as net income after all expenses have been deducted.

Based on the provided data for Harmony Biosciences Holdings, the net profit margin has exhibited fluctuations over the periods specified. It stood at 9.94% as of June 30, 2021, dipped to 4.93% by September 30, 2021, but then showed an upward trend reaching 12.87% by December 31, 2021. The trend continued to improve in the subsequent periods, with notable increases recorded in March 31, 2022 (16.74%), June 30, 2022 (18.16%), and peaking at 43.30% by December 31, 2022.

However, the net profit margin began to decline from this peak, falling to 20.49% by December 31, 2024, after hitting a low of 18.23% on September 30, 2024. Despite the fluctuations, Harmony Biosciences Holdings generally maintained a healthy net profit margin throughout the periods under review, with some intervals of significant profitability.

It is important for stakeholders to closely monitor these fluctuations and trends in the net profit margin as they provide insights into the company's operational efficiency and overall profitability.